Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol

NCT01451918 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Dyslipidaemia
Insulin Resistance

Interventions

DRUG: Resveratrol

Sponsor

University Health Network, Toronto

Collaborators

[object Object]